- Previous Close
8.02 - Open
8.06 - Bid 7.80 x 30000
- Ask 8.40 x 30000
- Day's Range
8.06 - 8.06 - 52 Week Range
6.52 - 20.10 - Volume
100 - Avg. Volume
905 - Market Cap (intraday)
49.59M - Beta (5Y Monthly) 1.58
- PE Ratio (TTM)
-- - EPS (TTM)
-2.14 - Earnings Date Apr 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 25, 2022
- 1y Target Est
19.50
Dr. Hönle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing, coating, and printing on three dimensional objects industries. The Disinfection segment is involved in activities in the areas of industrial water, surface, and air disinfection, including microbiological testing for various applications comprising disinfection in food industry, special lamps for life science, custom lamps, and microbiologic analyses. The company was founded in 1976 and is headquartered in Munich, Germany.
www.hoenle.de585
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: HNL.F
View MorePerformance Overview: HNL.F
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HNL.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HNL.F
View MoreValuation Measures
Market Cap
49.34M
Enterprise Value
96.11M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.50
Price/Book (mrq)
0.62
Enterprise Value/Revenue
1.00
Enterprise Value/EBITDA
26.92
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.46%
Return on Assets (ttm)
0.12%
Return on Equity (ttm)
-14.73%
Revenue (ttm)
96.38M
Net Income Avi to Common (ttm)
-12.97M
Diluted EPS (ttm)
-2.14
Balance Sheet and Cash Flow
Total Cash (mrq)
7.47M
Total Debt/Equity (mrq)
68.49%
Levered Free Cash Flow (ttm)
4.37M